“Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology – how should chemotherapy be conducted based on therapeutic drug monitoring?” (2023) Prospects in Pharmaceutical Sciences, 21(4), pp. 40–47. doi:10.56782/pps.167.